Liposome Drug Delivery Market Players Focus on Boosting Research Activities, Market Likely to Gain ~US$ 8 Bn in Revenues during 2019-2027: TMR

ALBANY, N.Y., Dec. 14, 2020 /PRNewswire/ -- Liposome refers to a spherical vesicle that has minimum one lipid bilayer. In healthcare sector, liposomes are utilized as a vehicle for pharmaceutical drugs and nutrients administration. Increased research and development activities in the healthcare sector worldwide are estimated to generate prominent expansion avenues in the global liposome drug delivery market in the forthcoming years.

Liposomes are gathering traction across healthcare sector owing to their ability to work as potential antiviral agents that will assist in decreasing economic burden and social impact occurred owing to the COVID-19 pandemic. Enterprises working in the liposome drug delivery market are focused on the development of liposomes that provide high solubility and extended circulating time to advance drug release profiles.

Request for Analysis of COVID-19 Impact on Liposome Drug Delivery Market -

Key Findings of Liposome Drug Delivery Market Report

    --  The liposome drug delivery market is likely to grow at CAGR of ~9% in
        the forecast period 2019-2027.
    --  Thus, the market is predicted to gather revenues of ~US$ 8 Bn by 2027
    --  The market was accounted for approximately US$ 3.6 Bn in 2018.
    --  Of all applications, the cancer therapy was dominant segment in the
        liposome drug delivery market during 2018.
    --  The aforementioned segment is slated to continue this growth trend in
        the forthcoming years.
    --  North America was dominant region in the market in 2018.
    --  Abovementioned region is estimated to maintain its dominant position
        during assessment period.
    --  The nature of liposome drug delivery market is moderately fragmented
        with presence of many well-entrenched enterprises.

Explore 199 pages of top-notch research, incisive insights, and detailed country-level projections on Liposome Drug Delivery Market (Product: Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, and Others; Technology: Stealth Liposome Technology, Non-PEGylated Liposome Technology, and DepoFoam Liposome Technology; and Application: Fungal Diseases, Pain Management, Cancer Therapy, Viral Vaccines, and Photodynamic Therapy) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 at

Liposome Drug Delivery Market: Key Driving Factors and Promising Avenues

    --  Liposome drug delivery is gaining popularity owing to many advantages it
        offers. One of the key advantages is the ability of this system to
        capture both lipophilic and hydrophilic compounds together with allowing
        a wide range of medications to be encapsulated by these vesicles. This
        scenario depicts that the global liposome drug delivery market will grow
        at rapid pace in the forthcoming years.
    --  The global liposome drug delivery market is estimated to grow at
        striking pace throughout the forecast period of 2019 to 2027. One of the
        key reasons attributed to this growth is rising cases of cancer.
        Liposome encapsulated drugs are widely utilized in the treatment of this
        deadly disease.
    --  The market for liposome drug delivery is predicted to gather higher
        revenues on the back of rising use of liposomes as drug delivery system
        owing to its numerous advantages. Moving forward, the market will expand
        at swift pace due to technological advancements and sturdy pipeline of
        medications in the forthcoming years.

Purchase the Liposome Drug Delivery Market Report -

Liposome Drug Delivery Market: Competitive Assessment

    --  Major enterprises in the global liposome drug delivery market are
        focused on discovery of novel lipid compositions. Apart from this,
        companies are eyeing optimization of the stability as well as drug
        vehiculization abilities of liposomes. All these activities are
        indicative of the promising growth curve of the global liposome drug
        delivery market in the forthcoming period.
    --  The list of important companies working in the liposome drug delivery
        market includes Astellas Pharma, Inc., Spectrum Pharmaceuticals, Inc.,
        Celsion Corporation, Gilead Sciences, Inc., Pacira BioSciences, Inc.,
        Ipsen Pharma, Novartis AG, Luye Pharma Group, Johnson & Johnson, and
        Takeda Pharmaceutical Company Limited.

Browse More Press Release -

The liposome drug delivery market can be segmented as follows:


    --  Liposomal Doxorubicin
    --  Liposomal Paclitaxel
    --  Liposomal Amphotericin B
    --  Others


    --  Stealth Liposome Technology
    --  Non-PEGylated Liposome Technology
    --  DepoFoam Liposome Technology


    --  Fungal Diseases
    --  Cancer Therapy
    --  Pain Management
    --  Viral Vaccines
    --  Photodynamic Therapy


    --  North America
    --  Europe
    --  Asia Pacific
    --  Latin America
    --  Middle East & Africa

Explore Transparency Market Research's award-winning coverage of the global Healthcare Industry:

Pulmonary Drug Delivery Devices Market: According to the report, the global pulmonary drug delivery devices market was valued at US$ 36,159.9 Mn in 2018 and is projected to expand at a CAGR of 2.7% from 2019 to 2027, increase in the prevalence and incidence of respiratory diseases across globe, increasing population of smokers across countries, rising prescription of the combination therapies, and rising research & development in the asthma & COPD treatment' are projected to drive the market

COPD Drug Delivery Devices Market: Some of the innovations that are likely to take place within the COPD drug delivery devices market are expected to focus on digital technologies linked with inhalers, chemistry and formulations, and design and device engineering. Moreover, research and development activities are being undertaken to improve targeted drug delivery to the lungs.

Drug and Gene Delivery Systems Market: The global drug and gene delivery systems market was valued at approximately US$ 512 Bn in 2016 and is anticipated to register a CAGR of above 6% from 2017 to 2025, to reach value of approximately US$ 917 Bn by 2025. The reagents & consumables segment is likely to fuel the global drug and gene delivery systems market from 2017 to 2025.

Browse Our Latest Reports -

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision."

Browse More Upcoming Reports by Transparency Market Research:


Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Press Release Source:

View original content:

SOURCE Transparency Market Research